Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (2.848)

61

PARP Inhibitors in Breast Cancer : a Short Communication

enthalten in: Current oncology reports | 2024

von Daly, G. | AlRawashdeh, M. | McGrath, J. | +6

62

BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair

enthalten in: Molecular cell | 2024

von Lim, P. | Zaman, M. | Feng, W. | +1

UpdateOf: bioRxiv. 2023 Apr 11;:. - PMID 37090587

63

Targeting BRCA and PALB2 in Pancreatic Cancer

enthalten in: Current treatment options in oncology | 2024

von Anbil, S. | Reiss, K.

64

Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer

enthalten in: Cancer | 2024

von Mutch, D. | Voulgari, A. | Chen, X. | +11

65

Bibliometric analysis of research trends on the combination of immune checkpoint inhibitors and PARP inhibitors in solid tumors

enthalten in: Heliyon | 2024

von Tan, Y. | Song, Q.

66

Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity

enthalten in: Journal of cancer research and clinical oncology | 2024

von He, S. | Wang, A. | Wang, J. | +8

67

BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer : state of the art and forthcoming challenges

enthalten in: Frontiers in oncology | 2024

von Collet, L. | Hanvic, B. | Turinetto, M. | +4

68

How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer : a review of literature

enthalten in: Frontiers in oncology | 2024

von Arcieri, M. | Tius, V. | Andreetta, C. | +10

69

PARP trapping is governed by the PARP inhibitor dissociation rate constant

enthalten in: Cell chemical biology | 2024

von Gopal, A. | Fernandez, B. | Delano, J. | +2

70

Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer

enthalten in: Journal of investigative medicine high impact case reports | 2024

von Chan, K. | Rutazanaa, D. | Wray, C. | +3